← all signals · sectors · research

HALOZYME THERAPEUTICS, INC. HALO

SIC 2836 — Biological Products, (No Diagnostic Substances) · CIK 1159036

This page lists every Interactive Market Data signal that fired on this company across fiscal years, with the calibrated net-of-cost forward-return prediction. Predictions use a triple → pair → singles fallback against our backtest panel (~32K (cik × fy) signal combos, net of execution costs at 5 bps half-spread + ADV-tiered borrow).

FY2025 long

1 signal fired · match: singles_avg

positive_eps_streak

HorizonPredicted net PnL
20 days-1.03%
60 days+1.48%
252 days (1y)+13.47%

FY2024 long

1 signal fired · match: singles_avg

positive_eps_streak

HorizonPredicted net PnL
20 days-1.03%
60 days+1.48%
252 days (1y)+13.47%

FY2023 long

1 signal fired · match: singles_avg

positive_eps_streak

HorizonPredicted net PnL
20 days-1.03%
60 days+1.48%
252 days (1y)+13.47%

FY2022 long

1 signal fired · match: singles_avg

positive_eps_streak

HorizonPredicted net PnL
20 days-1.03%
60 days+1.48%
252 days (1y)+13.47%

FY2020 short

2 signals fired · match: pair

accruals_quality_low, fcf_turn_positive

HorizonPredicted net PnL
20 days+0.70%
60 days-3.98%
252 days (1y)-9.43%

FY2018 short

3 signals fired · match: triple

dso_drift_severe, fcf_turn_negative, profit_to_loss

HorizonPredicted net PnL
20 days+0.78%
60 days-4.21%
252 days (1y)-9.86%

FY2017 long

1 signal fired · match: singles_avg

fcf_turn_positive

HorizonPredicted net PnL
20 days+1.81%
60 days+4.48%
252 days (1y)+19.70%

FY2012 short

1 signal fired · match: singles_avg

dso_drift_severe

HorizonPredicted net PnL
20 days-2.54%
60 days-11.34%
252 days (1y)-24.65%

Methodology: /methodology · Live JSON: /api/company/1159036/financials